Hepatitis
Prednisone bests anakinra, zinc for 90-day survival in severe alcohol-related hepatitis
WASHINGTON — Prednisone induced a higher 90-day survival rate and lower incidence of acute kidney injury compared with anakinra and zinc sulfate in patients with severe alcohol-associated hepatitis, according to late-breaking data.
‘We have to do better’: Liver health equity demands research investment to match burden
WASHINGTON — Funding research into liver disease, and reducing inequities in liver care, requires investment proportionate to its prevalence and burden on the health care system, said a keynote speaker at The Liver Meeting.
Alcohol-related hepatitis soars during pandemic, particularly in women, young adults
WASHINGTON — The number of cases of alcohol-related hepatitis increased by more than 60% from 2019 to 2021 in three California hospitals, with women and young adults most affected, according to research presented at The Liver Meeting.
Adults with hepatitis C at increased risk for developing active TB
People with hepatitis C, either treated or untreated, had an increased risk for developing active tuberculosis, according to data published in Clinical Infectious Diseases.
FDA rejects Gilead’s bulevirtide for hepatitis D, compensated liver disease
The FDA issued a complete response letter to Gilead indicating it cannot approve the company’s new drug application that seeks approval of bulevirtide for chronic hepatitis D virus infection and compensated liver disease.
Only one in 10 people with HCV and an indication offered PrEP, study finds
Despite indications for PrEP being prevalent among people with hepatitis C, most patients were unaware of PrEP, had never been offered PrEP and were not using PrEP, researchers found.
HIV, hepatitis C coinfection drives MI risk with increasing age
People with HIV and untreated hepatitis C virus have an 85% higher risk for type 1 MI per each 10-year increase in age, researchers reported.
Q&A: Hepatitis D screening, prevention in primary care
Healio spoke with John D. Scott, MD, MSc, FIDSA, chief digital health officer at UW Medicine, professor of allergy and infectious diseases at University of Washington and medical director at the Liver Clinic at Harborview Medical Center, to learn more about what PCPs can do to help prevent and screen for HDV.
Injection drug users with HCV history at risk for additional infections
An outbreak study based in West Virginia showed that people who inject drugs and have had hepatitis C are at risk for additional complications of injection drug use, including HIV hepatitis A and hepatitis B infection.
Top in GI: Viruses implicated in hepatitis surge; NASH is driving liver cancer deaths
A combination of viruses has been linked to an unexplained surge of severe hepatitis in children.